Published in

Springer Nature [academic journals on nature.com], British Journal of Cancer, 2(113), p. 226-231, 2015

DOI: 10.1038/bjc.2015.191

Links

Tools

Export citation

Search in Google Scholar

Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO